Efficacy and safety of the combination of bevacizumab with raltitrexed-based chemotherapy as second-line therapy in patients with metastatic colorectal cancer (mCRC): An interim analysis of a multicenter phase II trial

Zhu, JL; Li, S; Zhu, C

ANNALS OF ONCOLOGY, 2019; 30 ():